Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Dr Anil Diwan, CEO, NanoViricides Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
NanoViricides announces key data on Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
C4X Discovery Holdings PLC on expanding its portfolio - Clive Dix BSc PhD HonFBPhS, Interim Executive Chairman & CEO, C4X Discovery Holding
00:10:00
Shoper CEO Marcin Kuśmierz on Tech Valuations, VC Trends, and Polish Opportunities | Marcin Kuśmierz, CEO , Shoper SA.
00:10:00
Denarius Metals Nears High-Grade Gold Production in Colombia
00:00:00
Address how the brain uses sensation to inform action / Sandeep Robert Datta, MD, PhD Professor of Neurobiology, HMS
00:10:00
B3 Procurement - This is what it's like to work as a consultant | Anette Billing, CEO, B3 Consulting Group AB (publ) B3:STO
00:10:00
Mario Gabelli of GAMCO Investors provides insights into current market trends and stock picks including National Fuel Gas and T. Rowe Price.
00:10:00
Expert Insights on Online Reputation and Business Growth with Josh Green from The Mather Group | Josh Green, CEO,The Mather Group.
00:10:00
The 5 Investment Risks for 2023: Insights from Thys van Zyl | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
From Humble Beginnings to Success: Meet Lalit Dangi, Chairman of Liquid Group|Mr. Lalit Kumar Dangi,Chairman,Libord Securities Ltd.
00:10:00
Invests in the blockchain space to advance the adoption of cryptocurrency|Niraj Pant,General Partner,Polychain
00:10:00
Innovative Pharmaceutical Company Accelerates Growth and Forges Strategic Partnerships |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .
00:10:00
Wahid Nawabi, AeroVironment CEO, discusses quarterly earnings, international demand, and technological innovation in defense on 'Closing Bell Overtime'.